<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Institute of Clinical Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9553B924-A6AB-4C31-9B20-581368AE6259"><gtr:id>9553B924-A6AB-4C31-9B20-581368AE6259</gtr:id><gtr:firstName>Meng</gtr:firstName><gtr:surname>Li</gtr:surname><gtr:orcidId>0000-0002-4803-4643</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G117%2F560"><gtr:id>14E189A8-EEFA-46D6-9C67-034F4F437494</gtr:id><gtr:title>Functional identification of molecules promoting midbrain dopaminergic fate and neuritogenesis from embryonic stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G117/560</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Parkinson?s disease (PD) is a terminal progressive neurodegenerative disorder that affects 120,000 individuals in the UK alone. Most therapeutic strategies attempt to augment declining nigrostriatal dopamine function with drug or cell-based dopamine replacement strategies. However, the development of therapeutic paradigms via either approach is limited by a lack of sufficient understanding of the cellular and molecular mechanisms underlying differential vulnerability of substantia nigra dopaminergic (DA) neurons. 

My objectives therefore are to understand the molecular make up of the midbrain DA lineage, to investigate the roles played by these molecules in midbrain development, and to apply these molecules in promoting DA fate determination and axon growth from stem cells. This knowledge would facilitate the development of stem cell based therapeutic strategies for treating PD and may provide insight into development of pharmaceutical drug targets. The experimental design is based on DA differentiation using embryonic stem cell model system and modern mouse genetic approach. We have generated ES cells and mice that express eGFP specifically in midbrain dopaminergic neurons via gene targeting in the midbrain DA specific Pitx3 gene. We have shown that these ES cells serve as a valuable cellular system to track midbrain DA differentiation and functional evaluation of potential DA regulators. We have carried out a microarray analysis comparing the expression profile of embryonic day 12 DA neurons with that of Pitx3-deficient DA neurons and midbrain non-DA cells, using FACS purified cell population. This study identified candidate transcription factors and axon guidance cues which provide the fundation for works proposed in this application. 

The anticipated outcome of this application is the identification of key determinants for midbrain DA neurons and factors regulating neuritogenesis of these cells. From a therapeutic stand point, this work will identify nov target to push stem cells towards a dopaminergic fate in vitro which provides as a basis for their potential in developing pharmaceutical and cell based therapies for treating Parkinson?s disease. Furthermore, the proposed study also allows further development of the Pitx3-GFP, Pitx3-taulacZ and Pitx3-/- ES cell systems and this in turn would facilitate the future exploitation of these technologies in Parkinson?s related pharmaceutical drug screen program.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1811966</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Integrative Physiology</gtr:department><gtr:description>Wnt</gtr:description><gtr:id>3198ECDE-DE7B-48FC-9A6C-57F55F723026</gtr:id><gtr:impact>Publication 18315501</gtr:impact><gtr:outcomeId>CF068332406-1</gtr:outcomeId><gtr:partnerContribution>Data and conceptual exchange</gtr:partnerContribution><gtr:piContribution>Wnt and neural differentiation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lab visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>967ECE14-4252-4810-913F-5372DD5BE1F7</gtr:id><gtr:impact>Talked about potential stem cell application to family members of Parkinson's disease patients

not known</gtr:impact><gtr:outcomeId>8265BAC9BD6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EC FP7 funding</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C1A2C641-7C22-4ECD-9B14-0443ADE30C33</gtr:id><gtr:outcomeId>2944779799F0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>171841</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant - Generation and characterisation of cortical interneurons from human pluripotent stem cells</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>423F45F1-B9E2-485B-BF9D-52175A7F8F47</gtr:id><gtr:outcomeId>56a0d8a49353a0.46554854</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A mouse line that express a reporter in midbrain dopamine neurons and their axons</gtr:description><gtr:id>A953BA86-82FA-472F-ACC7-B16CABFDFDD6</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>2A7AF4E29DC</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transgenic mouse line</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>44AF5B4A-8D71-4674-A03B-631943913249</gtr:id><gtr:title>Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a553da3a8aca6eafea95d97708e2a0f2"><gtr:id>a553da3a8aca6eafea95d97708e2a0f2</gtr:id><gtr:otherNames>Tamburini C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5a82dcf0488033.82601596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4EA4758-C8A0-442A-AED7-0B36357F8BA5</gtr:id><gtr:title>Stem cell marker expression in the Bergmann glia population of the adult mouse brain.</gtr:title><gtr:parentPublicationTitle>Brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fe635e2d25053b8c57f8e82db09972a"><gtr:id>8fe635e2d25053b8c57f8e82db09972a</gtr:id><gtr:otherNames>Sottile V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8993</gtr:issn><gtr:outcomeId>38E6F2AB84A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C331C017-DDAA-4F92-9DE8-F4F5B1FC8251</gtr:id><gtr:title>Homeodomain protein Pitx3 maintains the mitotic activity of lens epithelial cells.</gtr:title><gtr:parentPublicationTitle>Mechanisms of development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240f4a28eeb1c976286ac462eb5fd913"><gtr:id>240f4a28eeb1c976286ac462eb5fd913</gtr:id><gtr:otherNames>Ho HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0925-4773</gtr:issn><gtr:outcomeId>F9AD93C36F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBB70284-7636-4096-A284-23159CBAB69C</gtr:id><gtr:title>Microspheres as a vehicle for biomolecule delivery to neural stem cells.</gtr:title><gtr:parentPublicationTitle>New biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce4480d8b1bf4b864b436d95f502e26"><gtr:id>fce4480d8b1bf4b864b436d95f502e26</gtr:id><gtr:otherNames>Gennet N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1871-6784</gtr:issn><gtr:outcomeId>2C93E882201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5911D0F7-3872-4D31-8A73-C3871B2135FC</gtr:id><gtr:title>Doublesex and mab-3-related transcription factor 5 promotes midbrain dopaminergic identity in pluripotent stem cells by enforcing a ventral-medial progenitor fate.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce4480d8b1bf4b864b436d95f502e26"><gtr:id>fce4480d8b1bf4b864b436d95f502e26</gtr:id><gtr:otherNames>Gennet N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>c96xphTt2Ee</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>926EB7ED-4FA6-41CF-9AD5-BD53272F29E6</gtr:id><gtr:title>Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baaa2f9f656ec90a26acb9c0e7656897"><gtr:id>baaa2f9f656ec90a26acb9c0e7656897</gtr:id><gtr:otherNames>Maxwell SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>DB44F113042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED75432E-19CE-4621-BEF4-F5CE1BD7B3CD</gtr:id><gtr:title>RNA polymerase II primes Polycomb-repressed developmental genes throughout terminal neuronal differentiation.</gtr:title><gtr:parentPublicationTitle>Molecular systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68983bdb8092d1303ea35bd54c6c5bb6"><gtr:id>68983bdb8092d1303ea35bd54c6c5bb6</gtr:id><gtr:otherNames>Ferrai C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>5a2fd805d74751.83446373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>377DFE65-35FA-490A-93C3-1C03629F4998</gtr:id><gtr:title>Early specification of dopaminergic phenotype during ES cell differentiation.</gtr:title><gtr:parentPublicationTitle>BMC developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2c73afbdbc695860c7ee2b9e6439ff3"><gtr:id>b2c73afbdbc695860c7ee2b9e6439ff3</gtr:id><gtr:otherNames>Parmar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-213X</gtr:issn><gtr:outcomeId>008F89234D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A99FA4F3-16F5-4A01-9B1F-39991017AA06</gtr:id><gtr:title>Microsphere-based tracing and molecular delivery in embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63caeff524c95c6d4b7c0646b618511f"><gtr:id>63caeff524c95c6d4b7c0646b618511f</gtr:id><gtr:otherNames>Tsakiridis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>AD34F218156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DF53E8F-B241-4A9D-B5C4-73E7240ED015</gtr:id><gtr:title>Clonal isolation of an intermediate pluripotent stem cell state.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b5fb39c8a6a5a99b41ff8604bbf872"><gtr:id>44b5fb39c8a6a5a99b41ff8604bbf872</gtr:id><gtr:otherNames>Chang KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_15180_20_23341219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9990D919-8C0D-443E-BBA4-2A93310860EB</gtr:id><gtr:title>Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdedf317f80720e645ab7065ad620ae5"><gtr:id>fdedf317f80720e645ab7065ad620ae5</gtr:id><gtr:otherNames>Gale E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>96C006CCFB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EE5F94B-4EB3-419C-9A6C-29791A1D53BF</gtr:id><gtr:title>DMRT5 Together with DMRT3 Directly Controls Hippocampus Development and Neocortical Area Map Formation.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c554ed8e7804d703ba9670d8b0315a9"><gtr:id>8c554ed8e7804d703ba9670d8b0315a9</gtr:id><gtr:otherNames>De Clercq S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>5a82dcefc2c405.81218290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75664779-DAA4-4110-963D-AE2E76166C6B</gtr:id><gtr:title>The doublesex-related Dmrta2 safeguards neural progenitor maintenance involving transcriptional regulation of Hes1.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bba3052ab8410a97a509aea8c265405"><gtr:id>0bba3052ab8410a97a509aea8c265405</gtr:id><gtr:otherNames>Young FI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a82dcf0064aa9.71639416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD333FB6-A7AD-4C0E-B277-D84209D6326A</gtr:id><gtr:title>Electrophysiological properties of embryonic stem cell-derived neurons.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3edfaa8071361f8a09af45e6d77da43"><gtr:id>f3edfaa8071361f8a09af45e6d77da43</gtr:id><gtr:otherNames>Risner-Janiczek JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>tKBfFtqyA5B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97372A5C-A814-42DD-97A0-B209704613A7</gtr:id><gtr:title>Expression profiles of Wnt genes during neural differentiation of mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9be7383dee97e7dc7413168efb27911"><gtr:id>d9be7383dee97e7dc7413168efb27911</gtr:id><gtr:otherNames>Nordin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn><gtr:outcomeId>8E90F04CE4E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6D8DD3-8C3D-4638-BA98-797FCEF12396</gtr:id><gtr:title>Deriving striatal projection neurons from human pluripotent stem cells with Activin A.</gtr:title><gtr:parentPublicationTitle>Neural regeneration research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b6b60831ac0c6fc7aea8a1eb70bbd5f"><gtr:id>4b6b60831ac0c6fc7aea8a1eb70bbd5f</gtr:id><gtr:otherNames>Noakes Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1673-5374</gtr:issn><gtr:outcomeId>58a5737b6e1fa9.95138074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D3674BD-4DCC-494F-B036-21250F8AE529</gtr:id><gtr:title>FolR1: a novel cell surface marker for isolating midbrain dopamine neural progenitors and nascent dopamine neurons.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce4480d8b1bf4b864b436d95f502e26"><gtr:id>fce4480d8b1bf4b864b436d95f502e26</gtr:id><gtr:otherNames>Gennet N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58a5737b4308d8.73250889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E05DAA5A-57B4-4620-B419-6A906B6984D1</gtr:id><gtr:title>DLK1 promotes neurogenesis of human and mouse pluripotent stem cell-derived neural progenitors via modulating Notch and BMP signalling.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e06d3bb8bcec762e7ccf68c1263171fc"><gtr:id>e06d3bb8bcec762e7ccf68c1263171fc</gtr:id><gtr:otherNames>Surmacz B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>brWhJtSyqHz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A75B9EB-E6E6-4A8E-B590-F2830D3594F6</gtr:id><gtr:title>Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/930a3ba7f3cacd8f5c8d6c4b458b0e14"><gtr:id>930a3ba7f3cacd8f5c8d6c4b458b0e14</gtr:id><gtr:otherNames>Cambray S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_15180_20_22588303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>309CEF49-FBC9-45CF-B5BC-FBC6EDB491B2</gtr:id><gtr:title>Rmst is a novel marker for the mouse ventral mesencephalic floor plate and the anterior dorsal midline cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f495bfc05bcfd8740cdc133afafafdc8"><gtr:id>f495bfc05bcfd8740cdc133afafafdc8</gtr:id><gtr:otherNames>Uhde CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>hC41f6TFuqp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F44C9FB-1E66-422A-9DA5-5A037ED5A317</gtr:id><gtr:title>Generation of human embryonic stem cell reporter lines expressing GFP specifically in neural progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c03f5fa6af3b608456373d4219704878"><gtr:id>c03f5fa6af3b608456373d4219704878</gtr:id><gtr:otherNames>Noisa P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>G5SfWpncA5X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B68B0234-460D-41D4-BA09-F9E041951799</gtr:id><gtr:title>FoxP1 promotes midbrain identity in embryonic stem cell-derived dopamine neurons by regulating Pitx3.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32fb2465ab64426d54110925278bf12e"><gtr:id>32fb2465ab64426d54110925278bf12e</gtr:id><gtr:otherNames>Konstantoulas CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>KGqxpNwHHJ2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0660D7B0-4447-4D7A-AF93-327415C9ED37</gtr:id><gtr:title>Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5f391e73485143b33a44702f7e27925"><gtr:id>d5f391e73485143b33a44702f7e27925</gtr:id><gtr:otherNames>Jaeger I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>iFH3Xa8HAVy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>138E748D-9A7B-4200-AF41-6B6B94C9B5D0</gtr:id><gtr:title>Effects of in ovo electroporation on endogenous gene expression: genome-wide analysis.</gtr:title><gtr:parentPublicationTitle>Neural development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f1124fbd6c98eca0e3c16ed69bc2304"><gtr:id>1f1124fbd6c98eca0e3c16ed69bc2304</gtr:id><gtr:otherNames>Farley EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1749-8104</gtr:issn><gtr:outcomeId>MQfrKLweRGF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EAF55C9-68ED-4781-9849-CECE0024ED8B</gtr:id><gtr:title>Potential application of embryonic stem cells in Parkinson's disease: drug screening and cell therapy.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240f4a28eeb1c976286ac462eb5fd913"><gtr:id>240f4a28eeb1c976286ac462eb5fd913</gtr:id><gtr:otherNames>Ho HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>39D40B3EF5F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CDF2B74-BEC9-4A50-8234-4E2FA2013F6E</gtr:id><gtr:title>A mouse model for tracking nigrostriatal dopamine neuron axon growth.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63d14ceb0ee8312fc20da42f78dce467"><gtr:id>63d14ceb0ee8312fc20da42f78dce467</gtr:id><gtr:otherNames>Vives J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn><gtr:outcomeId>F4BADDFC99F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G117/560</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>